Details for New Drug Application (NDA): 050706
✉ Email this page to a colleague
The generic ingredient in MERREM is meropenem. There are thirty-two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the meropenem profile page.
Summary for 050706
Tradename: | MERREM |
Applicant: | Pfizer |
Ingredient: | meropenem |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1GM/VIAL | ||||
Approval Date: | Jun 21, 1996 | TE: | AP | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 500MG/VIAL | ||||
Approval Date: | Jun 21, 1996 | TE: | AP | RLD: | Yes |
Expired US Patents for NDA 050706
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | MERREM | meropenem | INJECTABLE;INJECTION | 050706-001 | Jun 21, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | MERREM | meropenem | INJECTABLE;INJECTION | 050706-003 | Jun 21, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription